Articles |
the Second Department of Internal Medicine and Clinical Laboratory Science, Yamaguchi University School of Medicine, Yamaguchi, Japan. Presented in part at the 66th Scientific Sessions of the American Heart Association, Atlanta, Ga, November 8-11, 1993.
Correspondence to Masunori Matsuzaki, MD, PhD, The Second Department of Internal Medicine, Yamaguchi University School of Medicine, 1144 Kogushi, Ube, Yamaguchi 755, Japan.
The thoracic aorta is frequently involved in atherosclerotic lesions associated with familial hypercholesterolemia (FH). Transesophageal echocardiography (TEE) allows quantitative evaluation of the wall properties of the thoracic aorta. Using TEE, we tested whether atherosclerosis of the thoracic aorta in FH could be improved by cholesterol-lowering therapies. The subjects investigated were 22 FH patients and 22 age-matched normal subjects. The descending aorta (DA) was divided into four longitudinal portions of equal length. Atheromatous lesions of each portion of the DA were scored by character and extension of lesions by biplane two-dimensional TEE. The scores of atheromatous lesions from all four portions of the DA were added together to give the total atheromatous score (TAS). We also measured instantaneous dimensional changes of the DA in a cardiac cycle by M-mode TEE and blood pressure by a cuff method and calculated the stiffness parameter ß (ln[SBP/DBP]/[Dmax-Dmin]/Dmin), where SBP is the systolic arterial blood pressure, DBP is the diastolic arterial blood pressure, Dmax is the maximum aortic dimension during the ejection period, and Dmin is the minimum aortic dimension during the preejection period. TAS was higher in FH (3.70±1.32) than normal (0.62±0.54, P<.0001) subjects. ß in FH (10.35±4.87) was greater than in normal (5.10±1.25, P<.0001) subjects, but there were no significant differences of DA dimensions between the groups. In both normal subjects and FH patients, ß correlated with age (r=.52, P<.02 and r=.59, P<.005, respectively). In FH patients, ß and TAS correlated well with pretreatment total cholesterol levels (r=.43, P<.05 and r=.60, P<.005, respectively). In 12 of 22 FH patients, strict cholesterol-lowering therapies with diet and cholesterol-lowering drugs (pravastatin and probucol) were undertaken for 13 months. Cholesterol levels were significantly decreased from 333±45 to 219±39 mg/dL (P<.0001); this was associated with significant decreases in ß and TAS (from 9.88±5.03 to 7.88±3.92, P<.005, and from 3.61±1.50 to 2.94±1.22, P<.0005, respectively). In FH patients, the incidence and severity of morphological and physiological atherosclerosis of the DA were significantly higher than in age-matched normal subjects. A significant regression of atherosclerosis was achieved by strict cholesterol-lowering therapies in relatively young FH patients.
Key Words: transesophageal echocardiography atherosclerosis thoracic descending aorta familial hypercholesterolemia cholesterol-lowering therapy
This article has been cited by other articles:
![]() |
R. N. Khouzam Mobile Aortic Atheroma Leading to a Cerebrovascular Accident Circulation, February 10, 2009; 119(5): e192 - e192. [Full Text] [PDF] |
||||
![]() |
S. De Castro, E. Di Angelantonio, A. Celotto, M. Fiorelli, I. Passaseo, F. Papetti, S. Caselli, A. Marcantonio, A. Cohen, and N. Pandian Short-term evolution (9 months) of aortic atheroma in patients with or without embolic events: a follow-up transoesophageal echocardiographic study Eur J Echocardiogr, January 1, 2009; 10(1): 96 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Prasad A Study on Regression of Hypercholesterolemic Atherosclerosis in Rabbits by Flax Lignan Complex Journal of Cardiovascular Pharmacology and Therapeutics, December 1, 2007; 12(4): 304 - 313. [Abstract] [PDF] |
||||
![]() |
D. Bainbridge Aortic assessment for cardiac surgical procedures. Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2006; 10(2): 158 - 161. [Abstract] [PDF] |
||||
![]() |
G. Saliashvili, W. W. Davis, M. T. Harris, N.-A. Le, and W. V. Brown Simvastatin Improved Arterial Compliance in High-Risk Patients Vascular and Endovascular Surgery, November 1, 2004; 38(6): 519 - 523. [Abstract] [PDF] |
||||
![]() |
R. Arroyo-Espliguero, N. Mollichelli, P. Avanzas, E. Zouridakis, V. R Newey, D. K Nassiri, and J. C. Kaski Chronic inflammation and increased arterial stiffness in patients with cardiac syndrome X Eur. Heart J., November 2, 2003; 24(22): 2006 - 2011. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Oliver and D. J. Webb Noninvasive Assessment of Arterial Stiffness and Risk of Atherosclerotic Events Arterioscler Thromb Vasc Biol, April 1, 2003; 23(4): 554 - 566. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sugioka, T. Hozumi, R. R. Sciacca, Y. Miyake, I. Titova, G. Gaspard, R. L. Sacco, S. Homma, and M. R. Di Tullio Impact of Aortic Stiffness on Ischemic Stroke in Elderly Patients Stroke, August 1, 2002; 33(8): 2077 - 2081. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sen, S. M. Oppenheimer, J. Lima, and B. Cohen Risk Factors for Progression of Aortic Atheroma in Stroke and Transient Ischemic Attack Patients Stroke, April 1, 2002; 33(4): 930 - 935. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Ferrier, M. H. Muhlmann, J.-P. Baguet, J. D. Cameron, G. L. Jennings, A. M. Dart, and B. A. Kingwell Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension J. Am. Coll. Cardiol., March 20, 2002; 39(6): 1020 - 1025. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Willens and K. M. Kessler Transesophageal Echocardiography in the Diagnosis of Diseases of the Thoracic Aorta* : Part II--Atherosclerotic and Traumatic Diseases of the Aorta Chest, January 1, 2000; 117(1): 233 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. O. Toikka, P. Niemi, M. Ahotupa, H. Niinikoski, J. S. A. Viikari, T. Ronnemaa, J. J. Hartiala, and O. T. Raitakari Large-Artery Elastic Properties in Young Men : Relationships to Serum Lipoproteins and Oxidized Low-Density Lipoproteins Arterioscler Thromb Vasc Biol, February 1, 1999; 19(2): 436 - 441. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |